Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 8 July 2003
Vol. 2003, Issue 190, p. tw257
[DOI: 10.1126/stke.2003.190.tw257]


DIFFERENTIATION Specifying Cell Fate with Bcl-2 Family Members

The Bcl-2 family of proteins is best known for their roles in programmed cell death and consists of antiapoptotic members (Bcl-2 and Bcl-XL, for example) and proapoptotic members (Bax and Bak, for example). Haughn et al. provide evidence that Bcl-2 and Bcl-XL also specify cell fate in hematopoietic cell differentiation. When the multipotent hematopoietic cells (FDCP-Mix) cells were deprived of interleukin 3 (IL-3), overexpression of Bcl-2 resulted in myeloid cells (granulocytes, macrophages, and monocytes); whereas overexpression of Bcl-XL resulted in erythroid cells. By replacing the Bcl-2 homology 4 domain (BH4) of Bcl-2 with that of Bcl-XL, IL-3 withdrawal led to the production of erythroid cells, just like those seen with Bcl-XL overexpression. Thus, the BH4 domain is essential for the difference in cell fate. Immunoblots showed that only overexpression of Bcl-2 decreased Raf-1, a kinase in the mitogen-activated protein kinase cascade, without decreasing the mRNA for Raf-1 and without affecting the expression of other Raf isoforms. Coexpression of Raf-1, either the wild type or a kinase-inactive truncated version, along with Bcl-2 resulted in erythroid cells in response to IL-3 withdrawal. Geldamycin, an inhibitor of the chaperone heat shock protein 90, decreased Raf-1 levels in Bcl-XL, which resulted in the production of myeloid cells. Thus, the authors propose that Bcl-2 influences Raf-1 stability, which serves as a switch for differentiation. Normal levels of Raf-1 are associated with an erythroid cell fate, whereas loss of Raf-1 (in the presence of overexpressed Bcl-2) is associated with myeloid cell fates. These data support the expansion of roles for Bcl-2 proteins beyond cell survival into cell fate specification.

L. Haughn, R. G. Hawley, D. K. Morrison, H. von Boehmer, D. M. Hockenbery, BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiations. J. Biol. Chem. 278, 25158-25165 (2003). [Abstract] [Full Text]

Citation: Specifying Cell Fate with Bcl-2 Family Members. Sci. STKE 2003, tw257 (2003).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882